Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Substance abuse and movement disorders

Identifieur interne : 001985 ( Main/Curation ); précédent : 001984; suivant : 001986

Substance abuse and movement disorders

Auteurs : John C. M. Brust [États-Unis]

Source :

RBID : ISTEX:D1C76009C21225E4BFF8BE04388D04ABCF2D8274

Descripteurs français

English descriptors

Abstract

An array of movement disorders is associated with ethanol, illicit drugs, and tobacco. Heavy ethanol users experience withdrawal tremor and, less often, withdrawal parkinsonism, chorea, and myoclonus. Asterixis is a feature of hepatic failure. On the other hand, ethanol can ameliorate essential tremor and myoclonus‐dystonia. Among opioid drugs, meperidine can precipitate myoclonus. Severe parkinsonism affected users of a synthetic meperidine analog contaminated with 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine. Spongiform leukoencephalopathy, sometimes with chorea and myoclonus, occurred in inhalers of heroin vapor (chasing the dragon). Psychostimulants including cocaine acutely cause stereotypies and dyskinesias. Phencyclidine toxicity causes myoclonus. Tobacco use, on the other hand, protects against Parkinson's disease. Clinicians need to consider substance abuse in patients with unexplained movement disorders. © 2010 Movement Disorder Society.

Url:
DOI: 10.1002/mds.22599

Links toward previous steps (curation, corpus...)


Links to Exploration step

ISTEX:D1C76009C21225E4BFF8BE04388D04ABCF2D8274

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Substance abuse and movement disorders</title>
<author>
<name sortKey="Brust, John C M" sort="Brust, John C M" uniqKey="Brust J" first="John C. M." last="Brust">John C. M. Brust</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:D1C76009C21225E4BFF8BE04388D04ABCF2D8274</idno>
<date when="2010" year="2010">2010</date>
<idno type="doi">10.1002/mds.22599</idno>
<idno type="url">https://api.istex.fr/document/D1C76009C21225E4BFF8BE04388D04ABCF2D8274/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001237</idno>
<idno type="wicri:Area/Istex/Curation">001237</idno>
<idno type="wicri:Area/Istex/Checkpoint">000664</idno>
<idno type="wicri:doubleKey">0885-3185:2010:Brust J:substance:abuse:and</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:20721928</idno>
<idno type="wicri:Area/PubMed/Corpus">001616</idno>
<idno type="wicri:Area/PubMed/Curation">001616</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001591</idno>
<idno type="wicri:Area/Ncbi/Merge">002E01</idno>
<idno type="wicri:Area/Ncbi/Curation">002E01</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002E01</idno>
<idno type="wicri:Area/Main/Merge">001E21</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:10-0474314</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000899</idno>
<idno type="wicri:Area/PascalFrancis/Curation">002420</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000818</idno>
<idno type="wicri:doubleKey">0885-3185:2010:Brust J:substance:abuse:and</idno>
<idno type="wicri:Area/Main/Merge">002405</idno>
<idno type="wicri:Area/Main/Curation">001985</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Substance abuse and movement disorders</title>
<author>
<name sortKey="Brust, John C M" sort="Brust, John C M" uniqKey="Brust J" first="John C. M." last="Brust">John C. M. Brust</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Harlem Hospital Center and Columbia, University College of Physicians and Surgeons, New York, New York</wicri:regionArea>
<placeName>
<region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2010-10-15">2010-10-15</date>
<biblScope unit="vol">25</biblScope>
<biblScope unit="issue">13</biblScope>
<biblScope unit="page" from="2010">2010</biblScope>
<biblScope unit="page" to="2020">2020</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">D1C76009C21225E4BFF8BE04388D04ABCF2D8274</idno>
<idno type="DOI">10.1002/mds.22599</idno>
<idno type="ArticleID">MDS22599</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Ethanol</term>
<term>Heroin</term>
<term>Humans</term>
<term>Movement Disorders (etiology)</term>
<term>Myoclonus</term>
<term>Nervous system diseases</term>
<term>Pethidine</term>
<term>Substance abuse</term>
<term>Substance-Related Disorders (complications)</term>
<term>ethanol</term>
<term>heroin</term>
<term>meperidine</term>
<term>myoclonus</term>
<term>psychostimulant</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Substance-Related Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Movement Disorders</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Humans</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Abus de substance</term>
<term>Ethanol</term>
<term>Héroïne</term>
<term>Myoclonie</term>
<term>Pathologie du système nerveux</term>
<term>Péthidine</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">An array of movement disorders is associated with ethanol, illicit drugs, and tobacco. Heavy ethanol users experience withdrawal tremor and, less often, withdrawal parkinsonism, chorea, and myoclonus. Asterixis is a feature of hepatic failure. On the other hand, ethanol can ameliorate essential tremor and myoclonus‐dystonia. Among opioid drugs, meperidine can precipitate myoclonus. Severe parkinsonism affected users of a synthetic meperidine analog contaminated with 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine. Spongiform leukoencephalopathy, sometimes with chorea and myoclonus, occurred in inhalers of heroin vapor (chasing the dragon). Psychostimulants including cocaine acutely cause stereotypies and dyskinesias. Phencyclidine toxicity causes myoclonus. Tobacco use, on the other hand, protects against Parkinson's disease. Clinicians need to consider substance abuse in patients with unexplained movement disorders. © 2010 Movement Disorder Society.</div>
</front>
</TEI>
<double idat="0885-3185:2010:Brust J:substance:abuse:and">
<INIST>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Substance Abuse and Movement Disorders</title>
<author>
<name sortKey="Brust, John C M" sort="Brust, John C M" uniqKey="Brust J" first="John C. M." last="Brust">John C. M. Brust</name>
<affiliation wicri:level="2">
<inist:fA14 i1="01">
<s1>Department of Neurology, Harlem Hospital Center and Columbia, University College of Physicians and Surgeons</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">10-0474314</idno>
<date when="2010">2010</date>
<idno type="stanalyst">PASCAL 10-0474314 INIST</idno>
<idno type="RBID">Pascal:10-0474314</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000899</idno>
<idno type="wicri:Area/PascalFrancis/Curation">002420</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000818</idno>
<idno type="wicri:doubleKey">0885-3185:2010:Brust J:substance:abuse:and</idno>
<idno type="wicri:Area/Main/Merge">002405</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Substance Abuse and Movement Disorders</title>
<author>
<name sortKey="Brust, John C M" sort="Brust, John C M" uniqKey="Brust J" first="John C. M." last="Brust">John C. M. Brust</name>
<affiliation wicri:level="2">
<inist:fA14 i1="01">
<s1>Department of Neurology, Harlem Hospital Center and Columbia, University College of Physicians and Surgeons</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint>
<date when="2010">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Ethanol</term>
<term>Heroin</term>
<term>Myoclonus</term>
<term>Nervous system diseases</term>
<term>Pethidine</term>
<term>Substance abuse</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Abus de substance</term>
<term>Myoclonie</term>
<term>Pathologie du système nerveux</term>
<term>Ethanol</term>
<term>Héroïne</term>
<term>Péthidine</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">An array of movement disorders is associated with ethanol, illicit drugs, and tobacco. Heavy ethanol users experience withdrawal tremor and, less often, withdrawal parkinsonism, chorea, and myoclonus. Asterixis is a feature of hepatic failure. On the other hand, ethanol can ameliorate essential tremor and myoclonus-dystonia. Among opioid drugs, meperidine can precipitate myoclonus. Severe parkinsonism affected users of a synthetic meperidine analog contaminated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Spongiform leukoencephalopathy, sometimes with chorea and myoclonus, occurred in inhalers of heroin vapor (chasing the dragon). Psychostimulants including cocaine acutely cause stereotypies and dyskinesias. Phencyclidine toxicity causes myoclonus. Tobacco use, on the other hand, protects against Parkinson's disease. Clinicians need to consider substance abuse in patients with unexplained movement disorders.</div>
</front>
</TEI>
</INIST>
<ISTEX>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Substance abuse and movement disorders</title>
<author>
<name sortKey="Brust, John C M" sort="Brust, John C M" uniqKey="Brust J" first="John C. M." last="Brust">John C. M. Brust</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:D1C76009C21225E4BFF8BE04388D04ABCF2D8274</idno>
<date when="2010" year="2010">2010</date>
<idno type="doi">10.1002/mds.22599</idno>
<idno type="url">https://api.istex.fr/document/D1C76009C21225E4BFF8BE04388D04ABCF2D8274/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001237</idno>
<idno type="wicri:Area/Istex/Curation">001237</idno>
<idno type="wicri:Area/Istex/Checkpoint">000664</idno>
<idno type="wicri:doubleKey">0885-3185:2010:Brust J:substance:abuse:and</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:20721928</idno>
<idno type="wicri:Area/PubMed/Corpus">001616</idno>
<idno type="wicri:Area/PubMed/Curation">001616</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001591</idno>
<idno type="wicri:Area/Ncbi/Merge">002E01</idno>
<idno type="wicri:Area/Ncbi/Curation">002E01</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002E01</idno>
<idno type="wicri:Area/Main/Merge">001E21</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Substance abuse and movement disorders</title>
<author>
<name sortKey="Brust, John C M" sort="Brust, John C M" uniqKey="Brust J" first="John C. M." last="Brust">John C. M. Brust</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Harlem Hospital Center and Columbia, University College of Physicians and Surgeons, New York, New York</wicri:regionArea>
<placeName>
<region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2010-10-15">2010-10-15</date>
<biblScope unit="vol">25</biblScope>
<biblScope unit="issue">13</biblScope>
<biblScope unit="page" from="2010">2010</biblScope>
<biblScope unit="page" to="2020">2020</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">D1C76009C21225E4BFF8BE04388D04ABCF2D8274</idno>
<idno type="DOI">10.1002/mds.22599</idno>
<idno type="ArticleID">MDS22599</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Humans</term>
<term>Movement Disorders (etiology)</term>
<term>Substance-Related Disorders (complications)</term>
<term>ethanol</term>
<term>heroin</term>
<term>meperidine</term>
<term>myoclonus</term>
<term>psychostimulant</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Substance-Related Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Movement Disorders</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Humans</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">An array of movement disorders is associated with ethanol, illicit drugs, and tobacco. Heavy ethanol users experience withdrawal tremor and, less often, withdrawal parkinsonism, chorea, and myoclonus. Asterixis is a feature of hepatic failure. On the other hand, ethanol can ameliorate essential tremor and myoclonus‐dystonia. Among opioid drugs, meperidine can precipitate myoclonus. Severe parkinsonism affected users of a synthetic meperidine analog contaminated with 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine. Spongiform leukoencephalopathy, sometimes with chorea and myoclonus, occurred in inhalers of heroin vapor (chasing the dragon). Psychostimulants including cocaine acutely cause stereotypies and dyskinesias. Phencyclidine toxicity causes myoclonus. Tobacco use, on the other hand, protects against Parkinson's disease. Clinicians need to consider substance abuse in patients with unexplained movement disorders. © 2010 Movement Disorder Society.</div>
</front>
</TEI>
</ISTEX>
</double>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001985 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 001985 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Curation
   |type=    RBID
   |clé=     ISTEX:D1C76009C21225E4BFF8BE04388D04ABCF2D8274
   |texte=   Substance abuse and movement disorders
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024